Skip to main content
. 2013 Jan 1;3(1):9–22. doi: 10.1534/g3.112.004622

Table 3. Reversion of the lys2:InsE-A14 allele in mlh3 strains.

Genotype n Mutation Rate (×10−7) Relative to WT Phenotype
MLH3 110 4.71 (3.87–5.11) 1.0 +
mlh3Δ 110 26.5 (23.5–30.4) 5.7
mlh3-E31A 15 30.5 (16.7–51.6) 6.5
mlh3-N35A 15 31.2 (25.6–44.4) 6.7
mlh3-A41F 15 27.9 (17.1–34.3) 6.0
mlh3-G63R 15 23.8 (18.2–37.1) 5.1
mlh3-K80E 15 16.0 (15.1–27.7) 3.4
mlh3-K83A 15 5.24 (3.49–6.34) 1.1 +
mlh3-R96A 15 14.8 (6.42–40.6) 3.2
mlh3-G97A 15 16.6 (11.8–26.0) 3.6
MLH3 + empty vector 11 4.42 (1.02-6.05) 1 +
MLH3 + pGAL10-MLH3 11 39,100 (15,700-79,900) 8850
MLH3 + pGAL10-mlh3E31A 11 47,800 (28,700-85,900) 10,800
MLH3 + pGAL10-mlh3R96A 11 23,500 (5910-38,400) 5320
MLH3 + pGAL10-mlh3G97A 11 96,000 (45,800-156,000) 21,700
mlh1Δ + empty vector 11 218,000 (121,000-283,000) 49,300

The lys2:InsE-A14 SK1 strain EAY1062 and mlh3 derivatives (Table 1) were examined for reversion to Lys+. EAY1269 (lys2:InsE-A14, S288c strain) and an mlh1Δ derivative containing the indicated overexpression plasmids were tested for reversion to Lys+. n, the number of independent cultures tested from at least two independently constructed strains. Median mutation rates are presented with 95% confidence intervals, and relative mutation rates compared with the wild-type strain are shown. WT, wild type.